Validity of the UK early access to medicines scheme criteria for Remdesivir use in patients with COVID-19 disease

Detalles Bibliográficos
Autores principales: Daunt, Anna, Perez-Guzman, Pablo N., Liew, Felicity, Hauck, Katharina, Costelloe, Ceire E., Thursz, Mark R., Cooke, Graham, Nayagam, Shevanthi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The British Infection Association. Published by Elsevier Ltd. 2020
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306204/
https://www.ncbi.nlm.nih.gov/pubmed/32579980
http://dx.doi.org/10.1016/j.jinf.2020.06.049

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306204/
https://www.ncbi.nlm.nih.gov/pubmed/32579980
http://dx.doi.org/10.1016/j.jinf.2020.06.049

Ejemplares similares